Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Calderaro

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
Nature Genetics|May 8, 2012
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaCécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, et al.
European Urology|October 5, 2015
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary CarcinomasJulien Calderaro, Julien Masliah-Planchon, Wilfrid Richer, et al.
Oncoimmunology|February 7, 2014
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenomaKarine Poussin, Camilla Pilati, Gabrielle Couchy, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2017
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysisCharlotte E Costentin, Thomas Decaens, Alexis Laurent, et al.
Cancer Discovery|March 26, 2026
Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric studyJan Clusmann, Paul-Henry Koop, David Y Zhang, et al.
Journal of Hepatology|March 12, 2018
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activationShirley Abitbol, Rajae Dahmani, Cédric Coulouarn, et al.
Journal of Hepatology|August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinomaMarianne Ziol, Angela Sutton, Julien Calderaro, et al.
Liver Cancer|March 23, 2026
Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative StudyRami Rhaiem, Ammar Abdo, Julien Calderaro, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Nature Genetics|May 8, 2012
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaCécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, et al.
European Urology|October 5, 2015
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary CarcinomasJulien Calderaro, Julien Masliah-Planchon, Wilfrid Richer, et al.
Oncoimmunology|February 7, 2014
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenomaKarine Poussin, Camilla Pilati, Gabrielle Couchy, et al.
Hepatology Communications|June 27, 2024
Selective internal radiation therapy for unresectable HCC: The SIRT downstaging studyHélène Regnault, Julia Chalaye, Athena Galetto-Pregliasco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2017
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysisCharlotte E Costentin, Thomas Decaens, Alexis Laurent, et al.
Cancer Discovery|March 26, 2026
Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric studyJan Clusmann, Paul-Henry Koop, David Y Zhang, et al.
Journal of Hepatology|March 12, 2018
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activationShirley Abitbol, Rajae Dahmani, Cédric Coulouarn, et al.
Journal of Hepatology|August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinomaMarianne Ziol, Angela Sutton, Julien Calderaro, et al.
Liver Cancer|March 23, 2026
Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative StudyRami Rhaiem, Ammar Abdo, Julien Calderaro, et al.
Hepatology (Baltimore, Md.)|March 26, 2019
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver DiseaseJie Yang, Eric Trépo, Pierre Nahon, et al.
Pageof 19